Long-Term Follow-up of Humanized and Murine CD19 CAR-T Cell Therapy for B-Cell Malignancies

被引：0
|
作者：
Zhang, Yinqiang [1 ,2 ]
Du, Mengyi [1 ,2 ]
Liao, Danying [1 ,2 ]
Xie, Wei [1 ,2 ]
Xiong, Wei [3 ]
Mei, Heng [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Peoples R China
[2] Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China
[3] Wuhan Sian Med Technol Co Ltd, Wuhan, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180440
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
    Wang, Jia
    Yuan, Ji-jun
    Mu, Juan
    Li, Qing
    Mou, Nan
    Yang, Zhen-xing
    Li, Wei
    Li, Lanfang
    Zhao, Peiqi
    Wang, Xianhuo
    Pu, Yedi
    Zhang, Huilai
    Deng, Qi
    BLOOD, 2019, 134
  • [32] Toxicities of CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Turtle, Cameron J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S42 - S49
  • [33] Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes
    Khvorost, Darya
    Kendall, Brittany
    Jazirehi, Ali R.
    CELLS, 2024, 13 (08)
  • [34] CD19-Specific CAR-T Cell Treatment of 115 Children and Young Adults with Acute B Lymphoblastic Leukemia: Long-term Follow-up
    Wang, Yu
    Xue, Yu-juan
    Zuo, Ying-xi
    Jia, Yue-ping
    Lu, Ai-dong
    Zeng, Hui-min
    Zhang, Le-ping
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 945 - 955
  • [35] Effects of glucocorticoids on the proliferation of CD19 CAR-T cells targeting B-cell tumor cell lines
    邓昊彬
    China Medical Abstracts(Internal Medicine), 2022, 39 (01) : 58 - 59
  • [36] MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy
    Jin Jin
    Tianjiao Liu
    Jiali Cheng
    Jiao Meng
    Na Wang
    Liang Huang
    Xiaoxi Zhou
    Liting Chen
    Hui Luo
    Jianfeng Zhou
    Cancer Immunology, Immunotherapy, 2023, 72 : 2245 - 2256
  • [37] Preclinical evaluation of cyclophosphamide and fl udarabine combined with CD19 CAR-T in the treatment of B-cell hematologic malignancies in vivo
    Xia, Zhigang
    Tian, Mengyao
    Cheng, Yucai
    Yi, Wenfang
    Du, Zefan
    Li, Tianwen
    Wen, Yuchen
    Li, Lindi
    Liu, Yong
    Chen, Chun
    ONCOLOGY RESEARCH, 2024, 32 (06) : 1109 - 1118
  • [38] Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy
    Chen, Wei
    Ma, Yuhan
    Shen, Ziyuan
    Chen, Huimin
    Ma, Ruixue
    Yan, Dongmei
    Shi, Ming
    Wang, Xiangmin
    Song, Xuguang
    Sun, Cai
    Cao, Jiang
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Li, Zhenyu
    Zheng, Junnian
    Xu, Kailin
    Sang, Wei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy
    Jin, Jin
    Liu, Tianjiao
    Cheng, Jiali
    Meng, Jiao
    Wang, Na
    Huang, Liang
    Zhou, Xiaoxi
    Chen, Liting
    Luo, Hui
    Zhou, Jianfeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2245 - 2256
  • [40] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
12345